Literature DB >> 3766117

Withdrawal of phenobarbital and carbamazepine in epileptic patients: a preliminary neuropsychological report.

R Gallassi, S Lorusso, A Stracciari, A Morreale, G Procaccianti, A Baruzzi.   

Abstract

We systematically investigated the neuropsychological effects of controlled withdrawal of antiepileptic therapy with a battery of tests exploring intelligence, vigilance, attention, memory and sensori-motor performance. 16 patients without seizures for at least 2 years, 9 on therapy with phenobarbital (PB) and 7 with carbamazepine (CBZ), were examined 4 times over a period of 21 months. No significant correlation was found between drug levels and performance in the tests. The slight differences found between the PB and CBZ groups at full doses disappeared completely one year after withdrawal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3766117     DOI: 10.1111/j.1600-0404.1986.tb04626.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  2 in total

Review 1.  Risk-benefit assessment of carbamazepine in children.

Authors:  M N Seetharam; J M Pellock
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

2.  EEG changes induced by carbamazepine therapy at rest and during mental processes.

Authors:  M G Marciani; G L Gigli; M C Maschio; N Stefani; F Stefanini; G Bernardi
Journal:  Ital J Neurol Sci       Date:  1992-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.